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Abstract
Background—China faces a major increase in cardiovascular disease, yet there is limited
population-based data on risk factors, particularly in children.
Methods and Results—Fasting blood samples, anthropometry and blood pressure were
collected on 9,244 children and adults aged ≥7 years in late 2009 as part of the national China
Health and Nutrition Survey. Prevalent overweight, elevated blood pressure, and cardiometabolic
risk factors: glucose, HbA1c, triglycerides (TG), total cholesterol (TC), high and low density
lipoprotein cholesterol (HDL-C and LDL-C), and C-reactive protein (CRP) are presented.
Results—11% of Chinese children and 30% of Chinese adults are overweight. Rates of diabetes,
dyslipidemia, hypertension, and inflammation are high and increased with age and were associated
with urbanization. Approximately 42% of children have at least one of the following: pre-diabetes
or diabetes, hypertension, high TC, LDL-C, TG, and CRP and low HDL-C, as do 70% males and
60% females aged 18–40 years and >86% of males and females ≥40 years.
Conclusions—HbA1c findings suggest that as many as 29.4 million Chinese children and 415.8
million Chinese adults may be prediabetic or diabetic. The high prevalence in less urban areas and
across all income levels suggests that cardiometabolic risk is pervasive across rural and urban
China.
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Obesity rates in China across all age-gender groups have risen greatly in the past two
decades with particularly profound increases in BMI in children at the upper portion of the
distribution over the past decade1, 2. Concurrently, China has seen a major increase in
cardiometabolic risk, including high rates of hypertension, stroke and diabetes 3–5.
Underlying factors, such as diet and physical activity have also changed, including increased
consumption of refined carbohydrates, saturated fat, and added sugars, and declines in work,
leisure and transport-related physical activity 1, 6. These changes extend to poor and rural
areas, where the most rapid increases in overweight and obesity have recently occurred 7.
With China’s rapid economic growth, the burden of obesity has shifted to lower income
groups, mirroring what is typically seen in high income countries 8. Further complicating the
disease profile in China is the relatively higher cardiometabolic risk at relatively low body
mass index (BMI) 9 and at younger ages 10 in Asian populations as well as higher insulin
resistance relative to Western populations, even at the same level of BMI 11.
Using a representative, randomly selected sample from nine provinces across China, with
anthropometry, blood pressure measures and fasting blood samples from 9,244 individuals
aged 7 and older, we examine age and sex-specific prevalence of overweight, hypertension,
and biomarkers of diabetes, dyslipidemia, and inflammation. In addition, we examine
differences in cardiometabolic risk factors across levels of urbanization and income. Further,
we provide a comparative analysis of cardiometabolic risk relative to patterns in the US and
in other Asian countries.
Methods
The China Health and Nutrition Survey (CHNS) is the only large-scale longitudinal,
household-based survey in China 12. The CHNS has followed individuals randomly selected
from 228 communities and designed to represent a set of large provinces with a range of
economic and demographic variation, covering approximately 56% of China’s population,
including Liaoning, Shandong, Heilongjiang, Henan, Jiangsu, Hubei, Hunan, Guizhou, and
Guangxi (from north to south). The CHNS age and gender distribution is slightly older than
that of the Chinese census for 2009, since Muslim provinces which have higher fertility rates
that other parts of China were not included in the CHNS. Thus, CHNS includes
approximately 3% more individuals aged 60 and older and 3% fewer children and
adolescents compared to the national China census 12. A multistage, random cluster process
was used to draw the sample in each province, with the baseline survey in 1989, and fasting
blood collected for the first time in 2009. The analysis sample includes 9,244 individuals
aged 7 and older who provided fasting blood and anthropometry in 2009. Unlike other
surveys, the number of individuals who provided anthropometry is slightly greater (79 more
individuals) than those providing blood samples, likely due to the ordering of data
collection. There were no statistically significant differences in overweight and age between
individuals providing blood and anthropometry data. The sample of 2009 participants
represented 85.6% of the 2006 participants. Survey protocols, instruments, and the process
for obtaining informed consent for this study were approved by the institutional review
committees of the University of North Carolina at Chapel Hill, the National Institute of
Nutrition and Food Safety, Chinese Center for Disease Control and Prevention, and the
China-Japan Friendship Hospital, Ministry of Health.
During home visits spanning 3 days, survey data were collected through interviews with
each household member, including anthropometrics (height, weight, skinfold thicknesses
and body circumferences), detailed individual and household level dietary data, measures of
time spent in a wide range of daily activities and detailed individual, household and
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community socio-demographic data 12. Individuals older than 7 years visited a
neighbourhood clinic to have trained physicians collect fasting blood samples. Individuals
unable to attend the clinic had blood samples collected at home. To avoid missing children
in boarding schools and migrant workers, special efforts were made to schedule visits in
early morning or in the weekend when these participants were at home. All interviewers had
7 days of training provided by the collaborating teams and were overseen via site visits to
monitor data collection in each site visit by the University of North Carolina at Chapel Hill,
the China Centers for Disease Control and Prevention and the China-Japan Friendship
Hospital at selected locations in each province. Measurement of cardiometabolic disease risk
factors.
Following an overnight fast, blood was collected by venipuncture and tested immediately for
glucose and hemoglobin A1c (HbA1c). Plasma and serum samples were then frozen, and
stored at −86 °C for later laboratory analysis. All samples were analyzed in a national
central lab in Beijing (medical laboratory accreditation certificate ISO 15189:2007) with
strict quality control. We focus on blood pressure [systolic and diastolic BP] and biomarkers
of cardiometablic disease risk related to diabetes [fasting glucose measured with the GOD-
PAP method (Randox Laboratories Ltd., UK), HbA1c via high-performance liquid
chromatography system (model HLC-723 G7; Tosoh Corporation, Tokyo, Japan)];
dyslipidemia [total cholesterol (TC), high and low density lipoprotein cholesterol (HDL-C
and LDL-C) all measured using glycerol-phosphate oxidase method and the PEG-modified
enzyme method respectively by determiner regents (Kyowa Medex Co., Ltd, Tokyo, Japan )
and triglycerides (TG) using glycerol-phosphate oxidase method and the PEG-modified
enzyme method respectively by determiner regents (Kyowa Medex Co., Ltd, Tokyo, Japan ).
All lipids measures were on the Hitachi 7600 automated analyzer (Hitachi Inc., Tokyo,
Japan); inflammation [high sensitivity C-reactive protein (CRP)] via the
immunoturbidimetric method with Denka Seiken, Japan reagents (Hitachi 7600 automated
analyzer, Hitachi Inc., Tokyo, Japan). Levels of biomarkers were categorized to represent
risk using cutoff points recommended by the International Diabetes Federation (IDF) 13 or
in other published literature, with separate cutoff points for adults and children, and for
males and females where appropriate (Table 1).
Systolic (SBP) and diastolic (DBP) blood pressure were measured on the right arm, using
mercury sphygmomanometers with appropriate cuff sizes. Measures were collected in
triplicate after a 10 minute seated rest and the mean of the three measurements was used in
analyses. Adult hypertension was determined (according to the IDF cut point (SBP/DBP
≥140/90 mmHg) or taking blood pressure medication. For youth <18 years, hypertension
risk was defined as blood pressure above the 85th age, sex, and height-specific reference 14.
Overweight. Height was measured without shoes to the nearest 0.1 cm using a portable
SECA stadiometer; weight was measured without shoes and in light clothing to the nearest
0.1 kg on a calibrated beam balance. For adults, overweight is defined as BMI ≥25 kg/m2
and obesity as BMI ≥30 kg/m2 15. For youth, age- and sex-specific reference data for the
BMI ≥25 kg/m2 and BMI ≥30 kg/m2 equivalent cut-points from the International Obesity
Task Force were used to classify overweight and obesity to be consistent with the adult
definitions 16.
We also present population-specific BMI percentile distribution data by age to characterize
trends in BMI in children and adolescents in China over the past two decades. Using
quantile regression 17, 18, we characterize the mean BMI value associated with the
population-specific 95th percentile in 10 and 15 year olds from 1991 to 2009 based on a
regression of BMI data against age and age squared.
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Other variables—Age was recorded as the respondent’s age on the date of exam and
categorized into the following groups: 7–11, 12–17, 18–29, 30–39, 40–49, 50–59, 60–69,
and ≥70 years). Urbanicity is defined using a multidimensional 12 component urbanization
index that captures community-level physical, social, cultural, and economic environments
and which represents the heterogeneity that would be otherwise missed in a urban/rural
measure based only on population density (mean=67.2; SD=19.5) 19. A high urbanization
index represents a large population living closely together in a physical environment
providing an efficient transport system; a communication network; good-quality health care;
higher-level education; water, sewer, and electric lines. Household income is based on
detailed measures of all income-earning activities of all household members (mean=37,979,
SD=45,584 yuan). Tertiles of the urbanization index are used to define low, medium, and
high urbanicity and household income per capita.
Comparative cardiometabolic risk data—For wider comparison with the US, we used
most recently published data from the National Health and Nutrition Survey20, 21, 22 and
from the SEARCH for Diabetes in Youth study.23 We used nationally representative data
from the Korean Health and Nutrition Survey for individuals 10 and older collected in 2009,
which we analyzed for this paper. We conducted a systematic other literature search for
using the following key words alone and in combination: non–insulin-dependent diabetes
mellitus, type 2 diabetes mellitus, inflammation, children, adolescents, youth, and then for
adults to obtain nationally representative studies from Asia on this topic. We limited our
review only to national or very large-scale studies, which limited the number or included
studies.
Statistical Analyses
Statistical analyses were conducted using Stata (Release 11.0 SE, Stata Corporation, College
Station, TX). For descriptive analyses, percentages were calculated for categorical variables,
while means were calculated for continuous variables. The nonparametric test for trend was
used to test for age differences in cardiometabolic risk factors. Logistic regression models
were used to test for differences in risk factor prevalence by income or urbanization in age
and sex-stratified models.
Results
Approximately 12% of children and adolescents were overweight (Table 2). Obesity was
higher among the 7–11 year olds (3%) than among the 12–17 year olds (1%). Among adults,
overweight increased with age with highest rates in middle aged adults; approximately 30%
were overweight and 4% obese in the full sample.
All cardiometabolic risk factors (except low HDL-C in males) increased with age (p for
trend, p<0.0001), Figures 1A–1C. Pre-diabetes (IFG and impaired HbA1c) and diabetes
were highest in individuals older than 50 years (Figure 1A). Diabetes prevalence was similar
when based on fasting glucose or HbA1c, although pre-diabetes was higher using HbA1c.
Markers of dyslipidemia were comparatively high in females than males, with particularly
high prevalence of dyslipidemia in individuals over the age of 40 years (Figure 1B).
Similarly, elevated blood pressure and inflammation were comparatively higher in
individuals over the age of 40 years (Figure 1C). Values for all risk markers are shown in
Supplemental Table 1.
Of major public health relevance is the fact that in the pediatric population, 42% of children
aged 7–17 had at least one of the following cardiometabolic risk factors: pre-diabetes/
diabetes (HbA1c ≥5.7%), hypertension, high TC, high LDL, low HDL, high TG, high CRP.
In contrast, among adults aged 18 to 40 years, 70% of males and 60% of females had at least
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one risk factor, whereas approximately 83% of 40–60 year olds and over 90% of those 60
years and older had at least one elevated risk factor (Figure 2).
The observed elevated cardiometabolic risk factors at younger ages are consistent with
distribution of overweight in the CHNS pediatric population. Elsewhere, we have shown
that the mean BMI at the Chinese BMI 95th population-specific percentile at age 6 in 2006
was 24.8 kg/m2, whereas the US 95th population-specific percentile for 6 year olds was 22.2
kg/m2.1 Looking across the past two decades, the increase in mean BMI at the population-
specific BMI for China was biggest between 1991 and 2000 and between 2006 and 2009 and
that the increase has been comparatively larger in 10 year olds than 13 year olds.
After adjusting for age, higher urbanization was associated with higher levels of most risk
factors, although there were some sex differences in which specific markers related to
urbanicity, particularly in individuals over the age of 40 years (Table 4). Urbanization was
unrelated to impaired HbA1c and prehypertension (males and females). Comparing older
(≥40 yr) to younger (<40) individuals, some interesting relationships emerged. The positive
association of urbanization was stronger or seen only among older individuals for
overweight, IFG, diabetes (males and females), and low HDL (males only). The direction of
association of urbanization with risk indicators was opposite in older versus younger
females for high TG, and prehyptertension. For these risk factors, prevalence was lower in
the highest urbanization category among younger women, but higher in the highest
urbanization category among older women.
Associations of elevated cardiovascular risk factors with income were less consistent.
Higher income was associated with higher prevalence of overweight, diabetes and high TG
only in males. Income was unrelated to lipids (except LDL in highest tertile),
prehypertension, or CRP in males, and unrelated (positively) to all markers except
overweight in the highest tertile in females. Higher income was associated with lower risk of
high TG and high CRP in younger women, but with lower risk of diabetes and hypertension
in older women (Table 4).
Comparison of CHNS findings to findings in the United States and other Asian countries
We compare our CHNS findings with other nationally representative studies from the US
and the few published studies in Asia (Table 4). In Table 4A we show that diabetes and
inflammation prevalence was higher in CHNS adolescents than in US adolescents. Although
in the CHNS study we are unable to distinguish Type 1 and Type 2 diabetes, available
evidence for East Asia suggests almost no Type 1 insulin dependent diabetes among
youth 24–26. Comparisons of diabetes across China, South Korea and Taiwan (the only other
Asian countries with nationally representative data), suggests higher rates in China (Table
4B). For adults, on the other hand, diabetes prevalence is higher in South Korea, Hong
Kong, Singapore, and Malaysia than in China (Table 4C).
Discussion
The observed findings indicate strong age-related differences in overweight and
cardiometabolic risk. These estimates highlight the huge burden that the health care system
will need to confront. Of particular concern is the relatively high risk in the pediatric
population, important not only because of current impact on child health, but also because
risk tends to track into adulthood and even worsen. Based on HbA1c, the currently
recommended indicator for diabetes 27, we observed rates of diabetes of 0.9% and pre-
diabetes of 14.9% in those aged 7–17 years. Although the CHNS data do not match the
Chinese census (the CHNS sample has 3% more adults aged 60 and older and 3% fewer
under the age of 19), we can approximate the numbers of individuals affected using Chinese
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census data from 2009 28. Using the census data, our findings suggest that about 1.7 million
Chinese children under the age of 18 are diabetic and about 27.7 million are pre-diabetic.
The high rates of pre-diabetes as measured by HbA1c in youth (15%) and adults (30%)
portend a public health problem of massive proportion. Furthermore, over one-third of
children under the age of 18 had high levels of at least one cardiometabolic risk factor and
rates increase to 85% in those ≥40 years. Of additional concern is the high prevalence of
cardiometabolic risk in less urban areas and across all income levels.
Of additional concern is the observation that diabetes and inflammation rates are higher in
the Chinese pediatric population than in the US pediatric population and in other Asian
countries. In contrast, diabetes rates among adults were comparable to those in the US and
other Asian countries. Furthermore, obesity and pre-diabetes measured by HbA1c were
twice as high in 7–11 versus 12–18 year olds, it is possible that the younger cohorts who are
growing up in a very different environmental setting than the adolescents and adults grew up
in and are thus experiencing more dramatic health consequences than the adolescent Chinese
population. Coupled with the higher BMI values at the upper end of the distribution in
Chinese youth, relative to that in the US, UK and Australia1, the future health of the current
pediatric generation of Chinese youth is concerning, particularly given the higher
cardiometabolic risk at lower BMI in Asians 29–31.
We also observed age-related increases in cardiometabolic risk across all markers (with the
exception of low HDL in males), paralleling the increase in overweight in this population.
Diabetes, hypertension and inflammation were higher at older ages, despite a drop off in
overweight. More than three quarters of adults had at least one elevated cardiometabolic risk
factor, which increased to over 90% in individuals aged 60 and older. A recent study of
diabetes in a large national study of Chinese adults, ages 20 yr and older 5, used fasting and
2-hour glucose levels to define impaired fasting glucose and diabetes. We calculated age-
and sex-adjusted estimates (not shown) in the same age range as Yang to provide
comparison between our results and theirs. Our overall age and sex-adjusted estimate of
diabetes for adults aged 20 and older based on HbA1c (6.7%) is lower than the Yang age-
and sex-standardized estimate of 9.7% for the same age group. In comparison with Yang et
al., we observed an age- and sex-adjusted estimate of pre-diabetes of 30%, whereas Yang et
al., found 15.5%. Compared to the fasting glucose cutoff point of 100 mg/dl (5.6 mmol/l),
the HbA1c cutoff point of 5.7% is less sensitive but more specific and has a higher positive
predictive value to identify people at risk for later development of diabetes 32. Consistent
with their study, we find similar age distributions and higher rates of diabetes in men
compared to women. Our population study of cardiometabolic risk factors in Chinese adults
is the most current data available.
In addition to age-related increases in risk and high rates of cardiometabolic risk in youth,
we observed high prevalence of risk in less urban areas and in across all income levels,
suggesting pervasive risk across all parts of China. This is of major concern as these risk
factors were heretofore less common in rural China. In prior work, we have shown that the
burden of overweight is shifting from the rich to the poor in China and other countries, and
we have found comparatively rapid increases in obesity in rural and lower income
populations 7. In addition, we have shown an increased burden of obesity among women,
but an opposite trend in men 8. In the past in low in middle income countries, higher levels
of chronic disease risk were associated with affluence. Our findings suggest that as
cardiometabolic risk increases in China, even rural populations will be affected.
There are a few limitations to this analysis. This cross-sectional analysis does not examine
temporal changes in cardiometabolc risk factors owing to the fact that biomarker data were
only collected in the 2009 round of the CHNS. Despite the overall large sample size, some
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age and sex-specific subgroups are small, and thus may provide unstable estimates of
prevalence for rarer outcomes. Our main objective was to determine the prevalence of a
wide range of cardiometabolic risk factors by age and gender, and across urbanization and
income. To provide comparability, we used conventional, anthropometric and
cardiometabolic cutpoints. Nevertheless they may not represent true risk in this population
if, for example, disease develops at lower BMI in Asian versus other populations, which is
possible given higher visceral fat at the same level of BMI in Asians versus Europeans 9. We
used the BMI cutoff points of 25 and 30 kg/m2 for adults and the IOTF 25 and 30 kg/m2
equivalent for youth to allow for comparison of youth and adults. We did not exclude obese
individuals from this analysis as we were interested in estimating risk in the full Chinese
population; nonetheless when we exclude the 369 obese individuals in the sample from the
analysis we find very similar results that with rounding are almost identical. We are not able
to distinguish type 1 from type 2 diabetes in our sample, although no children reported
insulin injection use. Whereas it is possible that the comparatively higher rates of pre-
diabetes as measured by HbA1c in children versus adolescents could relate to type 1
diabetes, the rate of type 1 diabetes in China is among the lowest in the world, with an
estimate of 0.1 per 100,000/year 33. The differences in pre-diabetes and diabetes as
measured by HbA1c versus fasting glucose in youth, could possibly relate to differential
meaning of these measures in youth or transient increases in insulin resistance with
puberty 34–37. While we include comparative data from several countries, we were limited in
the availability of published data, particularly in South East and South Asian countries.
Important strengths of the study include its population based design, representation of a
wide range of urban and rural communities across China, its inclusion of fasting blood data
for children down to the age of 7 year, and the wide range of biomarkers collected. The data
from this national study suggests a high prevalence of overweight and elevated
cardiometabolic risk factors in China that is higher across age groups and is evident even in
the pediatric population. Further, rates were markedly high even in less urban and lower
income groups within China. Our HbA1c results suggest a very high burden of chronic
disease risk starting at a young age, with 1.7 million Chinese children 7–18 having diabetes
(HbA1c), another 27.7 million considered pre-diabetic. For adults, the observed findings that
suggest 82.1 million adults have diabetes and 334 million are pre-diabetic, are higher than
that of Yang 5. Further we provide evidence that this is just the beginning of high prevalence
of elevated cardiometabolic risk factors, given the increase in overweight with age.
Elsewhere we have discussed some of the economic burden of this coming crisis 6. The
observed findings foreshadow substantial and increasing chronic disease burden in China
over the next several decades.
Acknowledgments
We thank Ms. Frances Dancy, BS, UNC Carolina Population Center for her helpful administrative assistance,
Jennifer Poti, BS for helpful research assistance, Jim Terry, AB, Phil Bardsley, PhD, Donna Miles, PhD, and Dan
Blanchette, BA for programming and technical support. None of the individuals acknowledged received
compensation for any role in the study.
Funding
NIH (R01-HD30880, DK056350, R24 HD050924, R01-HD38700, R01-HL108427, and R21DK089306) with
added financial support from the Chinese Center for Disease Control and Prevention National Institute of Nutrition
and Food Safety and the China-Japan Friendship Hospital, Ministry of Health of China.
References Cited
1. Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr.
2010; 91:284S–88S. [PubMed: 19906804]
Yan et al. Page 7













2. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in
developing countries. Nutr Rev. 2012; 70:3–21. [PubMed: 22221213]
3. Lee CM, Huxley RR, Lam TH, et al. Prevalence of diabetes mellitus and population attributable
fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western
Pacific regions. Asia Pac J Clin Nutr. 2007; 16:187–92. [PubMed: 17215197]
4. Gu D, Gupta A, Muntner P, et al. Prevalence of cardiovascular disease risk factor clustering among
the adult population of China: results from the International Collaborative Study of Cardiovascular
Disease in Asia (InterAsia). Circulation. 2005; 112:658–65. [PubMed: 16043645]
5. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J
Med. 2010; 362:1090–1101. [PubMed: 20335585]
6. Popkin BM. Will China’s nutrition transition overwhelm its health care system and slow economic
growth? Health Aff (Millwood). 2008; 27:1064–76. [PubMed: 18607042]
7. Dearth-Wesley T, Wang H, Popkin BM. Obesity dynamics in China: The poor are catching up. Eur
J Clin Nutr. 2007; 18:1–6.
8. Jones-Smith JC, Gordon-Larsen P, Siddiqi A, Popkin BM. Emerging disparities in overweight by
educational attainment in Chinese adults (1989–2006). Int J Obes. 201110.1038/ijo.2011.134
9. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications
for policy and intervention strategies. Lancet. 2004; 363:157–163. [PubMed: 14726171]
10. Chan JCN, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and
pathophysiology. JAMA. 2009; 301:2129–2140. [PubMed: 19470990]
11. Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from caucasians and from each
other in their body mass index/body fat per cent relationship. Obes Rev. 2002; 3:141–6. [PubMed:
12164465]
12. Popkin BM, Du S, Zhai F, Zhang B. Cohort Profile: The China Health and Nutrition Survey--
monitoring and understanding socio-economic and health change in China, 1989–2011. Int J
Epidemiol. 2009; 39:1435–1440. [PubMed: 19887509]
13. International Diabetes Federation. 2006. The IDF consensus worldwide definition of the metabolic
syndromehttp://www.idf.org/webdata/docs/MetS_def_update2006.pdf
14. National High Blood Pressure Education Program. The fourth report on the diagnosis, evaluation,
and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114:555–576.
[PubMed: 15286277]
15. World Health Organisation International Association for the Study of Obesity International
Obesity TaskForce. The Asia-Pacific perspective: redefining obesity and its treatment. Health
Communications; Sydney: 2000. p. 1-56.
16. Cole TJ, Bellizz MC, Flegal KM, Dietz WH. Establishing a standard definition for child
overweight and obesity worldwide: international survey. Br Med J. 2000; 320:1240–1243.
[PubMed: 10797032]
17. Koenker R, Hallock, Kevin F. Quantile Regression. J Econ Perspect. 2001; 15:143–156.
18. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood.
Stat Med. 1992; 11:1305–1319. [PubMed: 1518992]
19. Jones-Smith JC, Popkin BM. Understanding community context and adult health changes in China:
development of an urbanicity scale. Soc Sci Med. 2011; 71:1436–1446. [PubMed: 20810197]
20. Martinson ML, Teitler JO, Reichman NE. Health across the life span in the United States and
England. Am J Epidemiol. 2011; 173:858–865. [PubMed: 21389038]
21. Dowd JB, Zajacova A, Aiello AE. Predictors of inflammation in U.S. children aged 3–16 years.
Am J Prev Med. 2010; 39:314–320. [PubMed: 20837281]
22. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk
factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey
(NHANES), 2001–2006. Arch Pediatr Adolesc Med. 2009; 163:371–377. [PubMed: 19349567]
23. SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among us youth:
prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006; 118:1510–
1518. [PubMed: 17015542]
Yan et al. Page 8













24. Kitagawa T, Owada M, Urakami T, Tajima N. Epidemiology of type 1 (insulin-dependent) and
type 2 (non-insulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Practice
Suppl. 1994; 24:S7-13.R.
25. Wei JN, Chuang LM, Lin CC, Chiang CC, Lin RS, Sung FC. Childhood diabetes identified in
mass urine screening program in Taiwan, 1993–1999. Diabetes Res Clin Practice. 2003; 59:201–
206.
26. Yang Z, Wang K, Li T, et al. Childhood diabetes in China: enormous variation by place and ethnic
group. Diabetes Care. 1998; 21:525–529. [PubMed: 9571336]
27. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.
Diabetes Care. 2009; 32:1327–1334. [PubMed: 19502545]
28. National Bureau of Statistics of China. Beijing: China Statistics Press. 2010. China Statistical
Yearbook 2010.
29. Nguyen TT, Adair LS, Suchindran CM, He K, Popkin BM. The association between body mass
index and hypertension is different between East and Southeast Asians. Am J Clin Nutr. 2009;
89:1905–1912. [PubMed: 19369374]
30. Nguyen T, Adair LS, Stevens J, Popkin BM. Prediction of hypertension by different
anthropometric indices in adults: the change in estimate approach. Public Health Nutr. 2010;
13:639–646. [PubMed: 19758482]
31. World Health Organization Expert Consultation. Appropriate body-mass index for Asian
populations and its implications for policy and intervention strategies. Lancet. 2004; 363:157–163.
[PubMed: 14726171]
32. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care
Suppl. 2010; 33:62–69.
33. The DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide
1990–1999. Diabetic Med. 2006; 23:857–866. [PubMed: 16911623]
34. Saaddine JB, Fagot-Campagna A, Rolka D, et al. Distribution of HbA(1c) levels for children and
young adults in the U.S: Third National Health and Nutrition Examination Survey. Diabetes Care.
2002; 25:1326–1330. [PubMed: 12145229]
35. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp
studies in 357 children. Diabetes. 1999; 48:2039–2044. [PubMed: 10512371]
36. Eldeirawi K, RBL. Predictors of hemoglobin A1c in a national sample of nondiabetic children: the
Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol. 2003;
157:624–632. [PubMed: 12672682]
37. Shultis WA, Leary SD, Ness AR, et al. Haemoglobin A1c is not a surrogate for glucose and insulin
measures for investigating the early life and childhood determinants of insulin resistance and Type
2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and
Children (ALSPAC). Diabetic Med. 2006; 23:1357–1363. [PubMed: 17116188]
38. Wei J-N, Sung F-C, Lin C-C, Lin R-S, Chiang C-C, Chuang L-M. National surveillance for type 2
diabetes mellitus in Taiwanese children. JAMA. 2003; 290:1345–1350. [PubMed: 12966126]
39. Chan JCN, Malik V, Jia W, et al. Diabetes in Asia. JAMA. 2009; 301:2129–2140. [PubMed:
19470990]
40. Ministry of Health. WHO Global Infobase: National Health Survey 2004. 2005. Singapore: World
Health Organization; 2005. Web site. http://www.who.int/infobase/
41. Mustafa N, Kamarudin NA, Ismail AA, et al. Prevalence of abnormal glucose tolerance and risk
factors in urban and rural Malaysia. Diabetes Care. 2011; 34:1362–1364. [PubMed: 21498788]
Yan et al. Page 9













Yan et al. Page 10














A–C. Cardiometabolic Risk Across Several Indicators by Age, 2009 China Health And
Nutrition Survey
Cutpoints shown in Table 1, abbreviations below
Over WT overweight
Imp FG impaired fasting glucose
Diab FG, diabetes based on fasting glucose
Imp A1c, impaired HbA1c
High A1c, hemoglobin HbA1c
High TG, triglycerides
High LDL, high low density lipoprotein cholesterol
Low HDL, low high density lipoprotein cholesterol
High TC, high total cholesterol
Hyper TN hypertension
High CRP, Inflammation measured by C-reactive protein
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Proportion of The CHNS Sample with at Least one Elevated Cardiometabolic Risk Factor
by Age Group (age 7–17 Years; age 18–39 Years, age 40–60 years; and age ≥60 Years
Proportion of the population with one or more of the following cardiometabolic risk factors:
impaired/diabetic (HbA1c ≥5.7%), hypertension (140/90, or age-sex specific percentiles for
pediatric population), high TC (≥200 mg/dL), high LDL (>130 mg/dL), low HDL(<40 mg/
dL), high TG (≥150 mg/dL), high CRP High CRP (≥3).
Yan et al. Page 12














Mean BMI value associated with the population-specific 95th percentile in 10 and 15 year
olds from 1991 to 2009
Based on quantile regression models of BMI data against age and age squared
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Table 1
Biomarkers, laboratory analyses methods and definitions of cardiometabolic risk, 2009 China Health and
Nutrition Survey fasting blood samples
Biomarker Risk Indicator Definition
Glucose Impaired fasting glucose Glucose ≥ 100 & < 126 mg/dL
Diabetes Glucose ≥ 126 mg/dL or taking diabetes medication
HbA1C Impaired glucose control HbA1c ≥ 5.7 & < 6.5%
Diabetes HbA1c ≥ 6.5% or taking diabetes medication
Total Cholesterol High TC ≥ 200 mg/dL
HDL-C Low HDL Male: < 40 mg/dL; female < 50 mg/dL; pediatric < 40 mg/dL
LDL-C High LDL > 130 mg/dL
Triglycerides High TG ≥ 150 mg/dL
High Sensitivity CRP High GRP ≥ 3 mg/dL
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Table 2
Mean BMI and percent overweight and obese in CHNS participants
Age Group N 4,417 Mean BMI (SD)
Overweight [BMI ≥ 25 (or pediatric
equivalent18)]; % (95% CI)
Obesity [BMI ≥ 30 (or pediatric
equivalent18)]; % (95% CI)
MALES
7–11* y 211 17.0 (2.9) 12.8 (10.5, 15.1) 3.2 (2.0, 4.4)
12–17* y 205 19.0 (3.4) 11.7 (9.5, 14.0) 1.4 (0.6, 2.2)
Total 7–17 y 416 18.0 (3.4) 12.3 (10.6, 13.9) 2.3 (1.6, 3.0)
18–29 y 374 22.2 (3.5) 20.8 (18.7, 22.9) 2.3 (1.5, 3.1)
30–39 y 611 24.0 (3.5) 31.0 (29.1, 32.9) 4.5 (3.7, 5.3)
40–49 y 857 24.0 (3.3) 35.2 (33.5, 36.8) 4.8 (4.1, 5.5)
50–59 y 973 23.5 (3.2) 29.8 (28.4, 31.3) 3.4 (2.8, 3.9)
60–69 y 659 23.2 (3.4) 30.0 (28.2, 31.7) 3.3 (2.6, 4.0)
≥70 y 431 22.5 (4.0) 22.6 (20.6, 24.6) 4.1 (3.2, 5.0)
Total ≥18 y 3905 23.3 (3.4) 29.5 (28.8, 30.3) 3.8 (3.5, 4.1)
Age Group N 4,827 Mean BMI (SD)
Overweight [BMI ≥ 25 (or pediatric
equivalent18)]; % (95% CI)
Obesity [BMI ≥ 30 (or pediatric
equivalent18)]; % (95% CI
FEMALES
7–11 y* 160 16.3 (3.0) 12.2 (9.6, 14.8) 3.0 (1.7, 4.3)
12–17 y* 184 19.0 (3.0) 8.2 (6.2, 10.2) 1.1 (0.3, 1.8)
Total 7–17y 344 18.0 (3.2) 10.1 (8.5, 11.7) 2.0 (1.2, 2.7)
18–29 y 392 21.0 (3.0) 9.4 (8.0, 10.9) 0.8 (0.3, 1.2)
30–39 y 665 23.0 (3.4) 21.7 (20.1, 23.3) 3.9 (3.1, 4.6)
40–49 y 1039 24.0 (3.3) 32.7 (31.2, 34.1) 4.4 (3.8, 5.1)
50–59 y 1098 24.0 (3.3) 36.4 (35.0, 37.9) 4.6 (4.0, 5.2)
60–69 y 697 24.0 (4.0) 36.1 (34.3, 38.0) 5.7 (4.8, 6.6)
≥70 y 519 23.1 (4.0) 28.2 (26.2, 30.2) 5.6 (4.6, 6.5)
Total ≥18 y 4410 23.4 (4.0) 29.9 (29.2, 30.6) 4.4 (4.1, 4.7)
Age Group N Mean BMI (SD)
Overweight [BMI ≥ 25 (or pediatric
equivalent18)]; % (95% CI)
Obesity [BMI ≥ 30 (or pediatric
equivalent18)]; % (95% CI)
TOTAL POPULATION
Pediatric 760 17.7 (3.3) 11.3 (10.1, 12.4) 2.2 (1.6, 2.7)
Adult 8315 23.4 (3.5) 29.7 (29.2, 30.2) 4.1 (3.9, 4.3)
*
7–17 year old age group broken into two categories given variation in growth for children and adolescents

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Yan et al. Page 19
Table 4
Comparison of CHNS findings to findings in the United States and other Asian countries using fasting blood
and C-reactive protein
Adolescent Males CHNS (Aged 12–18 years) United States Publications (Aged 12–19 years)
A. Adolescent Males only: CHNS and US adolescents
HbA1c≥6.5% 1.9% 0.5% NHANES20
CRP ≥3 mg/dL 12.1% 8.5% NHANES21
Glucose ≥ 126 mg/dL 0.9% 0.28% NHANES22; 0.22% SEARCH**23
IFG (100–126 mg/dL) 8.4% 20% NHANES22
Country Glucose ≥ 126 mg/dL Plus Medication IFG (100–126 mg/dL)
B. Adolescents: CHNS and other Asian countries
CHNS ages 12–17 0.9% 8.4%
South Korea, KHANES 10–17** 0.1% 5.3%
Taiwan 10–1838 <0.0 --
Country Glucose ≥ 126 mg/dL Plus Medication IFG (100–126 mg/dL)
C. Adults: CHNS, US, and other Asian countries
CHNS ages 18 and older 6.9% 20.0%
NHANES 18 and over 201122* 8.8% --
South Korea, KHANES 10–17** 8.1% 17.8%
Hong Kong39 9.8% --
Malaysia39 11.0% --
Thailand 200439 6.7 --




Source: NHANES weighted to be national representative22
**
Use of weighted data from the Korean Health and Nutrition Examination Survey 2009
***
For both males and females
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